PD Andreas  Roos (PhD)
Translational Research in Neuromuscular Disorders

PD Dr. rer. nat. Andreas Roos

Research Coordinator - Dept. of Neuropediatrics, University of Duisburg-Essen 🡵

Senior Scientist - Institute of Neurology - Düsseldorf University Hospital, Heinrich-Heine-Universität Düsseldorf 🡵

Adjunct Professor - University of Ottawa 🡵

Project Manager - NMD-GPS 🡵

GENOMIC AND PROTEOMIC SIGNATURES AS A GPS IN NEUROMUSCULAR DISEASES



Welcome dear visitor

As senior scientist I am working in the field of translational medicine with a main focus on neurodegenerative and neuromuscular disorders.

In order to understand the etiology of these diseases and to obtain a full picture, my work focusses on the identification of the genetic cause as well as on the discovery of the related pathophysiological consequences. For the latter purpose, various biochemical techniques including different proteomic approaches are applied by making use of in vitro and in vivo models as well as of patient-derived material.

I'd like to invite you to discover my field activity and related projects.

Best regards

Andreas Roos

 

News

Feed

12.07.2024

Recently accepted paper

HNRNPA1 de novo variant associated with early childhood onset, rapidly progressive generalized myopathy Journal of Neuromuscular Diseases ~ Roos A, Häusler M, Kollipara L, Topf A, Preusse C, Stucka R,...   mehr


12.07.2024

Recently accepted paper

A novel heterozygous deletion spanning exon 15 and 16 of the TCF4 gene is associated with mild skeletal muscle vulnerability in Pitt-Hopkins syndrome Skeletal Muscle ~ Chiu C, Depienne C, Kuechler A,...   mehr


11.07.2024

Recently accepted paper

Anti-Ku+ myositis - an acquired inflammatory protein aggregate myopathy Acta Neuropathologica ~ Holzer MT, Schneider U, Uruha A, Roos A, Hentschel A, Schänzer A, Weis J, Claeys KG, Schoser B,...   mehr


05.07.2024

Recently accepted paper

Lipid and protein changes in muscle of a patient with a heterozygous de novo variant in FAR1 Journal of Neuropathology & Experimental Neurology ~ Della Marina A, Schara-Schmidt U, Osmanovic A,...   mehr


02.07.2024

Recently published paper

Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering EBioMedicine ~ Nelke C, Schroeter CB, Barman S, Stascheit F,...   mehr


18.06.2024

Recently published paper

Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis Acta Neuropathologica ~ Schroeter CB, Nelke C, Stascheit F, Huntemann N, Preusse C,...   mehr